| mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
0.26 |
9e-06 |
| mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
0.23 |
2e-05 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
2e-05 |
| mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
0.22 |
5e-05 |
| mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
0.22 |
7e-05 |
| mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
7e-05 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
| mRNA |
methylstat |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.0001 |
| mRNA |
JW-74 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
0.0001 |